Home
>
National Drug Code (NDC)
>
Clindamycin Palmitate Hydrochloride
Clindamycin Palmitate Hydrochloride - 0574-0129-01 - (Clindamycin Palmitate Hydrochloride)
Drug Information of Clindamycin Palmitate Hydrochloride
| Product NDC: | 0574-0129 |
| Proprietary Name: | Clindamycin Palmitate Hydrochloride |
| Non Proprietary Name: | Clindamycin Palmitate Hydrochloride |
| Active Ingredient(s): | 75 mg/5mL & nbsp; Clindamycin Palmitate Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | GRANULE, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clindamycin Palmitate Hydrochloride
| Product NDC: | 0574-0129 |
| Labeler Name: | Paddock Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090902 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100121 |
Package Information of Clindamycin Palmitate Hydrochloride
| Package NDC: | 0574-0129-01 |
| Package Description: | 1 BOTTLE, GLASS in 1 CARTON (0574-0129-01) > 75 mL in 1 BOTTLE, GLASS |
NDC Information of Clindamycin Palmitate Hydrochloride
| NDC Code | 0574-0129-01 |
| Proprietary Name | Clindamycin Palmitate Hydrochloride |
| Package Description | 1 BOTTLE, GLASS in 1 CARTON (0574-0129-01) > 75 mL in 1 BOTTLE, GLASS |
| Product NDC | 0574-0129 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clindamycin Palmitate Hydrochloride |
| Dosage Form Name | GRANULE, FOR SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20100121 |
| Marketing Category Name | ANDA |
| Labeler Name | Paddock Laboratories, Inc. |
| Substance Name | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| Strength Number | 75 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |
